doranidazole has been researched along with fluorouracil in 1 studies
| Studies (doranidazole) | Trials (doranidazole) | Recent Studies (post-2010) (doranidazole) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 30 | 4 | 10 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | doranidazole (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, S; Kumai, T; Nakaya, S; Takezawa, N; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
1 other study(ies) available for doranidazole and fluorouracil
| Article | Year |
|---|---|
Effects of PR-350, a newly developed radiosensitizer, on dihydropyrimidine dehydrogenase activity and 5-fluorouracil pharmacokinetics.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Cytosol; Dihydrouracil Dehydrogenase (NADP); Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Half-Life; Humans; Imidazoles; Liver; Male; Oxidoreductases; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley | 2001 |